Inpatient and Outpatient Balloon Catheter Cervical Ripening

April 9, 2020 updated by: Rahana Abd Rahman, National University of Malaysia

A Comparison Between Inpatient and Outpatient Balloon Catheter Cervical Ripening: A Prospective Randomized Controlled Trial

A randomised controlled trial comparing cervical ripening using foley catheter as in- or outpatient setting.

Study Overview

Status

Completed

Detailed Description

The study evaluated the efficacy and safety of outpatient versus inpatient Foley catheter cervical ripening and patients' satisfaction. Sixty low-risk women were randomized to outpatient and inpatient management of intracervical Foley catheter digital insertion. The outpatient group was provided with verbal and written 24-hours contact information and instructions. Both groups were reassessed the next morning unless labor had begun or the catheter had dropped off.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kuala Lumpur
      • Cheras, Kuala Lumpur, Malaysia, 56000
        • UKM Medical Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • singleton
  • gestational age beyond 37 weeks
  • cephalic presentation
  • intact membranes
  • Bishop score less than 6
  • lives within 10km from National University Malaysia Medical Centre or able to reach within 30 minutes
  • readily available transport

Exclusion Criteria:

  • intrauterine death
  • intrauterine fetal growth restriction
  • estimated fetal weight more than 4000gram
  • fetal anomalies
  • abnormal pre-induction cardiotocograph
  • non-vertex presentation
  • unstable lie
  • sepsis
  • hypertension
  • allergy to latex
  • previous uterine scar
  • history of antepartum haemorrhage
  • parity of 6 and more
  • placenta praevia
  • suspected cephalopelvic disproportion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Foley catheter inpatient
Participants had intracervical ripening with foley catheter after admission into the ward.
Participants were assessed when labour was established or the following morning.
Active Comparator: Foley catheter outpatient
Participants had intracervical ripening with foley catheter and allowed home.
Participants were assessed when labour was established or the following morning.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caesarean section rate
Time Frame: From the time of recruitment until delivery
Percentage of Caesarean section
From the time of recruitment until delivery
Neonatal sepsis
Time Frame: From birth up to 30 days
Percentage of neonates with sepsis
From birth up to 30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal age
Time Frame: At the time of recruitment
Mean maternal age in years
At the time of recruitment
Ethnicity
Time Frame: At the time of recruitment
Percentage of each races
At the time of recruitment
Education level
Time Frame: At the time of recruitment
Percentage of participants with secondary or higher education level
At the time of recruitment
Occupation
Time Frame: At the time of recruitment
Percentage of participants who were professional or non professional or housewives
At the time of recruitment
Pre-pregnancy maternal body mass index
Time Frame: At the time of recruitment
Mean pre-pregnancy body mass index in kg/m2
At the time of recruitment
Parity
Time Frame: At the time of recruitment
Percentage of participants who are nulliparous or multiparous
At the time of recruitment
Gestation at recruitment
Time Frame: At the time of recruitment
Percentage of participants who were recruited at 40 or 40 weeks and 10 days
At the time of recruitment
Indication
Time Frame: At the time of recruitment
Percentage of participants who were induced based on indication
At the time of recruitment
Bishop score pre-induction
Time Frame: Pre-intervention
Mean Bishop score prior to induction. Unfavourable score has minimum score of 0 and maximum score of 5.
Pre-intervention
Bishop score at second assessment
Time Frame: From insertion of Foley catheter until labour established or the following morning
Mean Bishop score at second assessment. Unfavourable score has minimum score of 0 and maximum score of 5.
From insertion of Foley catheter until labour established or the following morning
Management at second assessment
Time Frame: At time of recruitment until delivery
Percentage of participants who had dinoprostone insertion or artificial rupture of membranes
At time of recruitment until delivery
Duration from induction until favourable Bishop score
Time Frame: At time of recruitment until delivery
Mean duration taken from induction until favourable Bishop score in hours
At time of recruitment until delivery
Augmentation with oxytocin
Time Frame: At time of recruitment until delivery
Percentage of participants who required oxytocin augmentation
At time of recruitment until delivery
Duration of oxytocin use
Time Frame: At time of recruitment until delivery
Mean duration of oxytocin use in minutes
At time of recruitment until delivery
Duration from amniotomy until delivery
Time Frame: At time of recruitment until delivery
Mean duration from amniotomy until delivery in hours
At time of recruitment until delivery
Duration from induction until delivery
Time Frame: At time of recruitment until delivery
Mean duration from induction until delivery in hours
At time of recruitment until delivery
Delivery within 24 hours
Time Frame: At time of recruitment until delivery
Percentage of participants who delivered within 24 hours from induction
At time of recruitment until delivery
Duration of inpatient stay
Time Frame: At time of recruitment until delivery
Mean duration of inpatient stay in hours
At time of recruitment until delivery
Total blood loss
Time Frame: At the time of delivery
Median blood loss in millilitres
At the time of delivery
Intrapartum pyrexia
Time Frame: At the time of delivery
Percentage of participants with intrapartum pyrexia
At the time of delivery
Primary postpartum haemorrhage
Time Frame: Immediately at delivery up to 42 days
Percentage of participants with primary postpartum haemorrhage
Immediately at delivery up to 42 days
Birth weight
Time Frame: At the time of delivery
Mean birth weight in grams
At the time of delivery
Arterial cord blood acidity or alkalinity
Time Frame: At the time of delivery
Mean arterial cord blood acidity or alkalinity
At the time of delivery
Neonatal white cell count
Time Frame: At the time of delivery
Mean neonatal white cell count in liter
At the time of delivery
Neonatal C-reactive protein
Time Frame: At the time of delivery
Median neonatal C-reactive protein in milligram per liter
At the time of delivery
Discomfort with foley catheter
Time Frame: At the time of recruitment until active phase of labour
Percentage of participants experienced discomfort with foley catheter
At the time of recruitment until active phase of labour
Ability to cope with discomfort
Time Frame: At the time of recruitment until active phase of labour
Percentage of participants able to cope with discomfort
At the time of recruitment until active phase of labour
Intention to use the method again
Time Frame: Through study completion until delivery
Percentage of participants who intend to use similar method in future
Through study completion until delivery
Feeling alone during induction
Time Frame: At the time of recruitment until delivery
Percentage of participants who felt lonely during induction
At the time of recruitment until delivery
Duration of sleep
Time Frame: At the time of recruitment until delivery
Duration of sleep during induction in hours
At the time of recruitment until delivery
Able to rest and relax
Time Frame: At the time of recruitment until delivery
Percentage of participants who are able to rest and relax
At the time of recruitment until delivery
Feeling of unsafe during cervical ripening
Time Frame: At the time of recruitment until active phase of labour
Percentage of participants who felt unsafe during cervical ripening
At the time of recruitment until active phase of labour
Embarrassed by the method
Time Frame: At the time of recruitment until active phase of labour
Percentage of participants who felt embarrassed by the method
At the time of recruitment until active phase of labour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2017

Primary Completion (Actual)

May 31, 2018

Study Completion (Actual)

May 31, 2018

Study Registration Dates

First Submitted

April 7, 2020

First Submitted That Met QC Criteria

April 9, 2020

First Posted (Actual)

April 13, 2020

Study Record Updates

Last Update Posted (Actual)

April 13, 2020

Last Update Submitted That Met QC Criteria

April 9, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • FF-2017-358

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caesarean Section; Infection

Clinical Trials on Foley catheter cervical ripening

Subscribe